Related Experiment Video
Updated: Jan 26, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer
1Department of Urology, Wuhan Asia General Hospital, Wuhan, China. drxinli@yahoo.com.
Objective:
microRNAs (miRNAs) abnormal expression was proved to regulate the bladder cancer (BC) development. Here, we aimed to investigate the role of miR-335 played in BC.
Materials And Methods:
Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot were used to examine the miR-335 and CRKL (CT10 regulator of kinase-like protein) expression level in BC. Methyl thiazolyl tetrazolium (MTT) and RT-qPCR were used to examine cell viability of BC cells. Cell transwell assay was used to assess the migratory ability of BC cells. The direct target of miR-335 in BC was verified by luciferase reporter assay.
Results:
The results showed that the expression of miR-335 and CRKL in normal and adjacent tissues showed no significant differences. Whereas, miR-335 expression in BC was significantly lower and CRKL expression was observably higher than normal. CRKL was verified as a specific target of miR-335 in BC cells and the relationship between CRKL and miR-335 expression was negatively correlated in BC tissues. Furthermore, CRKL siRNA group in BC cells remarkably inhibited cell proliferation and migration. MiR-335 mimic in BC cells remarkably curbed cell proliferation and migration and CRKL could reverse the proliferative and migratory ability of BC cells regulated by miR-335.
Conclusions:
miR-335 could suppress BC cell proliferation and migration by upregulating of CRKL.
Insights
MicroRNA-335 (miR-335) is downregulated in bladder cancer (BC) and suppresses tumor growth. Upregulating miR-335 inhibits BC cell proliferation and migration by targeting CRKL (CT10 regulator of kinase-like protein).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant microRNA (miRNA) expression is implicated in bladder cancer (BC) pathogenesis.
- Investigating the specific role of miR-335 in BC development is crucial for understanding disease mechanisms.
Purpose of the Study:
- To elucidate the function of miR-335 in bladder cancer.
- To determine the relationship between miR-335 and its potential target, CRKL, in BC.
Main Methods:
- Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot were used to assess miR-335 and CRKL expression.
- Cell viability was evaluated using MTT assays.
- Cell migration and invasion were assessed via Transwell assays.
- Luciferase reporter assays confirmed the direct targeting of CRKL by miR-335.
Main Results:
- miR-335 expression was significantly decreased, while CRKL expression was elevated in BC tissues compared to normal tissues.
- CRKL was identified as a direct target of miR-335, with a negative correlation between their expression levels in BC.
- Inhibition of CRKL or upregulation of miR-335 suppressed BC cell proliferation and migration.
- Overexpression of CRKL could reverse the inhibitory effects of miR-335 on BC cell behavior.
Conclusions:
- miR-335 acts as a tumor suppressor in bladder cancer.
- miR-335 inhibits BC cell proliferation and migration, potentially through the downregulation of its target gene, CRKL.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...

